Image

Subthalamic Nucleus, Akinesia and Parkinson's Disease

Subthalamic Nucleus, Akinesia and Parkinson's Disease

Recruiting
18-70 years
All
Phase N/A

Powered by AI

Overview

This program aims to understand the role of the subthalamic nucleus in the control of the movement in healthy humans and patients with Parkinson's disease, how the STN dysfunction contributes to akinesia and how the STN stimulation improves motor signs in PD patients .

Eligibility

Inclusion criteria for patients who will be operated

  1. Diagnosis of idiopathic Parkinson's disease (according to the criteria of the United Kingdom Parkinson's Disease Society Brain Bank)
  2. Age between 18 and 70;
  3. Motor complications in the form of fluctuations in motor state or dyskinesias induced by dopaminergic therapy, despite medical treatment optimum;
  4. Other medical conditions that are stable or do not interfere with the procedure proposed;
  5. Excellent responsiveness to levodopa (UPDRS motor score improvement greater than 50% in the acute levodopa test)
  6. Brain MRI without abnormality
  7. Normality of biological examinations
  8. Person who has voluntarily and informedly agreed to participate in the study (signature of a written consent)
  9. Patient with social health insurance

Criteria for non-inclusion of Parkinsonian patients who will be operated

  1. Contraindication to examinations necessary for inclusion
  2. Evolutionary psychiatric pathology;
  3. Dementia(MMS<24/30);
  4. Patients with a medical condition that makes surgery dangerous neuro-surgical;
  5. Bleeding-promoting diseases and laboratory test abnormalities clotting;
  6. Existence of contraindications to MRI (cardiac or neural pacemaker, clips ferromagnetic surgeries, implants and metal objects, foreign bodies intraocular, pregnancy, claustrophobia).
  7. Taking drugs interfering with coagulation for 1 month before intervention.
  8. Persons under guardianship, curatorship or any other administrative or judicial measure deprivation of rights and liberty

Selection criteria for non-operated patients

  1. Diagnosis of idiopathic Parkinson's disease (according to the criteria of the United Kingdom Parkinson's Disease Society Brain Bank);
  2. Age between 18 and 70;
  3. Other medical conditions that are stable or do not interfere with the proposed protocol;
  4. Presence of axial signs (gait and/or balance disorders) no improved by antiparkinsonian treatment
  5. Brain MRI without notable abnormality
  6. Normality of biological examinations
  7. Person who has voluntarily and informedly agreed to participate in the study (signature of a written consent)
  8. Patient with social health insurance

Criteria for non-inclusion of non-operated patients

  1. Contraindication to examinations necessary for inclusion
  2. Progressive psychiatric pathology;
  3. Dementia (MMS<24/30);
  4. Existence of contraindications to MRI (cardiac or neural pacemaker, clips ferromagnetic surgeries, implants and metal objects, foreign bodies intraocular, pregnancy, claustrophobia).
  5. Persons under guardianship, curatorship or any other administrative or judicial measuredeprivation of rights and liberty

Inclusion criteria for group 3 patients (already operated)

  1. Diagnosis of idiopathic Parkinson's disease (according to the criteria of the United Kingdom Parkinson's Disease Society Brain Bank);
  2. Bilateral deep brain stimulation of the subthalamic nucleus for more than 1 year
  3. Age between 18 and 70;
  4. Person who has voluntarily and informedly agreed to participate in the study (signature of a written consent)
  5. Patient with social health insurance

Criteria for non-inclusion of Parkinsonian patients (already operated)

  1. Contraindication to examinations necessary for inclusion
  2. Evolutionary psychiatric pathology;
  3. Dementia(MMS<24/30);
  4. Persons under guardianship, curatorship or any other administrative or judicial measure deprivation of rights and liberty

Inclusion criteria for healthy subjects

  1. Age between 18 and 70 years old
  2. Normal neurological examination
  3. Person who voluntarily and informedly agreed to participate in the study (signature of a written consent)
  4. Patient with social health insurance

Criteria for non-inclusion of healthy subjects

  1. Persons under guardianship, curatorship or any other administrative or judicial measure of deprivation of rights and freedom
  2. Existence of neurological, orthopedic or psychiatric history
  3. Existence of contraindications to MRI (cardiac or neural pacemaker, ferromagnetic surgical clips, implants and metallic objects, foreign bodies intraocular, pregnancy, claustrophobia).

Study details
    Parkinson's Disease

NCT01682668

Institut National de la Santé Et de la Recherche Médicale, France

25 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.